PatientsVille.com Logo

PatientsVille

Jurnista Side Effects

Common Jurnista Side Effects


The most commonly reported Jurnista side effects (click to view or check a box to report):

Disorientation (6)
Dyskinesia (4)
Withdrawal Syndrome (3)
Respiratory Failure (3)
Cardiac Failure (2)
Accidental Overdose (2)
Ileus Spastic (2)
Asthenia (2)
Restlessness (2)
Myoclonus (2)
Muscle Spasms (2)
Bile Duct Cancer (1)
Inadequate Analgesia (1)
Confusional State (1)
Altered State Of Consciousness (1)
Feeding Tube Complication (1)
Hepatic Enzyme Increased (1)
Gastrointestinal Disorder (1)
Depressed Level Of Consciousness (1)
Convulsion (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Jurnista Side Effects Reported to FDA

The following Jurnista reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Jurnista on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Metastases To Bone, Metastases To Kidney, Respiratory Failure, Neoplasm Malignant
This is a report of a 87-year-old male patient (weight: NA) from IT, suffering from the following symptoms/conditions: pain, who was treated with Jurnista (dosage: NA, start time: Jun 01, 2013), combined with:
  • Durogesic
  • Contramal
  • Deltacortene
  • Lanoxin
  • Cardioaspirin
  • Portex
  • Lixidol
  • Enantone
and developed a serious reaction and side effect(s). The consumer presented with:
  • Metastases To Bone
  • Metastases To Kidney
  • Respiratory Failure
  • Neoplasm Malignant
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Jurnista treatment in male patients, resulting in metastases to bone side effect. The patient was hospitalized.

Hepatic Enzyme Increased
This report suggests a potential Jurnista Hepatic Enzyme Increased side effect(s) that can have serious consequences. A 75-year-old female patient (weight: NA) from AU was diagnosed with the following symptoms/conditions: back pain and used Jurnista (dosage: NA) starting Apr 07, 2011. Soon after starting Jurnista the patient began experiencing various side effects, including:
  • Hepatic Enzyme Increased
Drugs used concurrently: NA. Although Jurnista demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hepatic enzyme increased, may still occur.

Disorientation, Altered State Of Consciousness, Joint Effusion, Speech Disorder, Weight Decreased, Gastrointestinal Disorder, Urosepsis, Confusional State
This Disorientation, Altered State Of Consciousness, Joint Effusion, Speech Disorder, Weight Decreased, Gastrointestinal Disorder, Urosepsis, Confusional State problem was reported by a physician from GERMANY. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Sep 20, 2010 this consumer started treatment with Jurnista (dosage: NA). The following drugs were being taken at the same time:
  • Pantoprazol
  • Glucocorticoids (10 Mg Per Day)
  • Ciprofloxacin
  • Calcilac Kt (500mg/400 Once Per Day)
  • Arcoxia 60
  • Bisoprolol Fumarate
  • Iron-(ii)-glycinsulfat Complex(ferrosanol Duodenal 100mg Capsules))
  • Mtx (Per Week)
When commencing Jurnista, the patient experienced the following unwanted symptoms/side effects:
  • Disorientation
  • Altered State Of Consciousness
  • Joint Effusion
  • Speech Disorder
  • Weight Decreased
  • Gastrointestinal Disorder
  • Urosepsis
  • Confusional State
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as disorientation, may become evident only after a product is in use by the general population.

Asthenia, Bile Duct Cancer, Ileus Spastic
This is a report of a male patient (weight: NA) from KOREA, REPUBLIC OF. The patient developed the following symptoms/conditions: NA and was treated with Jurnista (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Asthenia
  • Bile Duct Cancer
  • Ileus Spastic
The patient was hospitalized. This opens a possibility that Jurnista treatment could cause the above reactions, including asthenia, and some male subjects may be more susceptible.


Asthenia, Ileus Spastic
A male patient (weight: NA) from KOREA, REPUBLIC OF with the following symptoms/conditions: NA started Jurnista treatment (dosage: NA) on NS. Soon after starting Jurnista treatment, the subject experienced various side effects, including:
  • Asthenia
  • Ileus Spastic
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Jurnista.

Cardiac Failure, Disorientation
A 40-year-old male patient from GERMANY (weight: NA) experienced symptoms, such as: NA and was treated with Jurnista(dosage: NA). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Cardiac Failure
  • Disorientation
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Jurnista efficacy: NA.

Cardiac Failure, Disorientation
In this report, Jurnista was administered for the following condition: NA.A 40-year-old male consumer from GERMANY (weight: NA) started Jurnista treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Cardiac Failure
  • Disorientation
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Jurnista treatment could be related to the listed above side effect(s).

Accidental Overdose, Dyskinesia
This is a report of the following Jurnista side effect(s):
  • Accidental Overdose
  • Dyskinesia
A male patient from SWITZERLAND (weight: NA) presented with the following condition: NA and received a treatment with Jurnista (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Jurnista treatment could be associated with the listed above side effect(s).

Disorientation, Dyskinesia, Muscle Spasms, Myoclonus, Withdrawal Syndrome
This Jurnista report was submitted by a 49-year-old female consumer from SPAIN (weight: NA). The patient was diagnosed with: NA and Jurnista was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Disorientation
  • Dyskinesia
  • Muscle Spasms
  • Myoclonus
  • Withdrawal Syndrome
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Jurnista treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Disorientation, Dyskinesia, Muscle Spasms, Myoclonus, Withdrawal Syndrome
This is a report of a possible correlation between Jurnista use and the following symptoms/side effect(s):
  • Disorientation
  • Dyskinesia
  • Muscle Spasms
  • Myoclonus
  • Withdrawal Syndrome
which could contribute to an assessment of Jurnista risk profile.A 49-year-old female consumer from SPAIN (weight: NA) was suffering from NA and was treated with Jurnista (dosage: NA) starting NS.Other concurrent medications: NA.The patient was hospitalized.

Convulsion, Disorientation, Dyskinesia, Withdrawal Syndrome
A 49-year-old female patient from SPAIN (weight: NA) presented with the following symptoms: NA and after a treatment with Jurnista (dosage: NA) experienced the following side effect(s):
  • Convulsion
  • Disorientation
  • Dyskinesia
  • Withdrawal Syndrome
The treatment was started on NS. Jurnista was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Jurnista consumers.

Accidental Overdose, Respiratory Failure, Restlessness
In this report, a 85-year-old male patient from GERMANY (weight: NA) was affected by a possible Jurnista side effect.The patient was diagnosed with pain. After a treatment with Jurnista (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Accidental Overdose
  • Respiratory Failure
  • Restlessness
The following simultaneously used drugs could have led to this reaction:
  • Duragesic-100
The findings here stress that side effects should be taken into consideration when evaluating a Jurnista treatment.

Depressed Level Of Consciousness, Feeding Tube Complication, Inadequate Analgesia, Oral Intake Reduced, Respiratory Failure, Respiratory Paralysis, Restlessness
This is a report of a 85-year-old male patient from GERMANY (weight: NA), who used Jurnista (dosage: NA) for a treatment of pain. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Depressed Level Of Consciousness
  • Feeding Tube Complication
  • Inadequate Analgesia
  • Oral Intake Reduced
  • Respiratory Failure
  • Respiratory Paralysis
  • Restlessness
The following drugs could possibly have interacted with the Jurnista treatment
  • Duragesic-100
Taken together, these observations suggest that a Jurnista treatment could be related to side effect(s), such as Depressed Level Of Consciousness, Feeding Tube Complication, Inadequate Analgesia, Oral Intake Reduced, Respiratory Failure, Respiratory Paralysis, Restlessness.



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Jurnista Side Effects

    Did You Have a Jurnista Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Jurnista for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective